phase readout
saveNCT04925193: Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
ACTIVE_NOT_RECRUITINGupdated 17h ago
community read0 votes
Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Multiple Myeloma in Relapse
view source ↗
comments(0)
5-min edit window · permanent after that